ºù«Ӱҵ Gene Therapy Innovation and Manufacturing Centre - Strategic Business Case

Review the Strategic Business Case submitted by the University of ºù«Ӱҵ to ºù«Ӱҵ City Region LEP in application for funding towards the construction of the ºù«Ӱҵ Gene Therapy Innovation and Manufacturing Centre.

ºù«Ӱҵ Gene Therapy Manufacturing and Innovation Centre
ºù«Ӱҵ submitted a Strategic Business Case to the ºù«Ӱҵ City Region Local Enterprise Partnership on 21st April 2021 in application for a funding contribution towards the construction of the ºù«Ӱҵ Gene Therapy Innovation and Manufacturing Centre.
 
 
Any comments regarding the Strategic Business Case, and its development into a Full Business Case, are welcomed from partners and the general public.
 
Please direct these to James Cokeham, Regional Economic Development Manager, Partnerships and Regional Engagement: j.a.cokeham@sheffield.ac.uk
 

The ºù«Ӱҵ Gene Therapy Manufacturing and Innovation Centre

  • The ºù«Ӱҵ Gene Therapy Innovation and Manufacturing Centre (GTIMC) will be one of three cutting-edge hubs in the UK dedicated to advancing the clinical development of new genetic treatments
  • Gene therapy is a promising treatment option for a number of diseases that currently have no other cures including inherited disorders
  • The ºù«Ӱҵ Hub, which is the first in the north of England, is part of an £18 million network created by LifeArc and the Medical Research Council (MRC), with support from the Biotechnology and Biological Sciences Research Council (BBSRC)

Find out more